Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
IMPACT BIOMEDICAL INC.Impact Biomedical Inc. Reports $24.77 Million Net Loss in 2024 Fiscal Year
Stark Novus Financial Inc.Nu Ride Inc. Reports No Revenue for 2024 Following Bankruptcy, Sees Improved Net Loss
Inhibitor Therapeutics, Inc.Inhibitor Therapeutics Reports Financial Performance and Strategic Developments for Fiscal Year 2024
STRATUS PROPERTIES INCStratus Properties Reports $54.2 Million Revenue and $2 Million Net Income for Fiscal Year 2024
NATIONAL BANKSHARES INCNational Bankshares Reports 51.4% Decrease in Net Income for Fiscal Year 2024
Hongchang International Co., LtdHongchang International Reports Revenue Growth to $2.87 Million Despite Increased Net Loss
Entera Bio Ltd.Entera Bio Reports $9.5 Million Net Loss for Fiscal Year 2024, Revenue Increases to $181,000
Investview, Inc.Investview Reports 23% Revenue Decline for Fiscal Year Ending December 31, 2024
IMMUCELL CORP /DE/ImmuCell Corporation Reports 52% Increase in Product Sales for Fiscal Year 2024
Beachbody Company, Inc.Beachbody Reports $418.8 Million Revenue Decline and Strategic Shift to Affiliate Model
LAVA Therapeutics NVLAVA Therapeutics Reports $25.1 Million Net Loss and Revenue Growth to $12.0 Million for 2024
Medicus Pharma Ltd.Medicus Pharma Reports $11.2 Million Net Loss and Significant R&D Investment in 2024
GENELUX CorpGenelux Corp. Reports $29.9 Million Net Loss for 2024 Amid Decreased Revenue
Peraso Inc.Peraso Inc. Reports $14.2 Million Revenue for Fiscal Year 2024, Net Loss Decreases to $10.7 Million
BioXcel Therapeutics, Inc.BioXcel Therapeutics Reports $59.6M Net Loss and Increased Revenue in 2024
MIRA PHARMACEUTICALS, INC.MIRA Pharmaceuticals Reports $7.9 Million Net Loss, Advances Key Drug Candidates
ENTREPRENEUR UNIVERSE BRIGHT GROUPEntrepreneur Universe Bright Group Reports 15.5% Revenue Decline to $5.27 Million for Fiscal Year 2024
Velos Acquisition I Corp.M3-Brigade Acquisition V Corp. Reports $5.2 Million Net Income and Completes IPO
Forte Biosciences, Inc.Forte Biosciences Reports $35.5 Million Net Loss for Fiscal Year 2024
International Stem Cell CORPInternational Stem Cell Corporation Reports $9.1 Million Revenue for Fiscal Year 2024
NSTS Bancorp, Inc.NSTS Bancorp Reports $789,000 Net Loss for 2024, Improved from $4 Million Loss in 2023
QS Energy, Inc.QS Energy Reports $1.93 Million Net Loss for Fiscal Year 2024, No Revenue Generated
John Marshall Bancorp, Inc.John Marshall Bancorp Reports Significant Increase in Net Income to $17.1 Million for Fiscal Year 2024
OP BancorpOP Bancorp Reports 10.2% Increase in Total Assets to $2.37 Billion for 2024
LIQTECH INTERNATIONAL INCLiqTech International Reports 18.9% Revenue Decline for Fiscal Year 2024